Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence studies bridge the gap left from case detection, to estimate the true burden of the COVID-19 pandemic. While multiple anti-SARS-CoV-2 immunoassays are available, no gold standard exists. METHODS: This serial cros...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeed, Sahar, O’Brien, Sheila F., Abe, Kento, Yi, Qi-Long, Rathod, Bhavisha, Wang, Jenny, Fazel-Zarandi, Mahya, Tuite, Ashleigh, Fisman, David, Wood, Heidi, Colwill, Karen, Gingras, Anne-Claude, Drews, Steven J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459951/
https://www.ncbi.nlm.nih.gov/pubmed/34555095
http://dx.doi.org/10.1371/journal.pone.0257743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459951/
https://www.ncbi.nlm.nih.gov/pubmed/34555095
http://dx.doi.org/10.1371/journal.pone.0257743

Ejemplares similares